Cite

    Sisson, T. et al. (2021). Impact of induction strategy change on first‐year rejection in pediatric heart transplantation at a single center—From postoperative basiliximab to either postoperative anti‐thymocyte globulin or preoperative basiliximab. Clinical transplantation. 35 (6), p. n/a. [Online].